ZUG, Switzerland--(BUSINESS WIRE)--Turing Pharmaceuticals AG today announced that Nancy Retzlaff, Chief Commercial Officer, will testify before a U.S. House Committee on Oversight and Government Reform hearing on drug pricing on Tuesday, January 26. Turing, a privately held biopharmaceutical company focused on commercializing and developing innovative treatments for rare and neglected diseases and conditions, produces Daraprim, a drug to treat Toxoplasmosis, an infection that can be life-threatening for certain people.
